If I remember correctly Avecia manufactures iPlex in the EU on behalf of INSM. Therefore production and consumption of iPlex will most probably take place in the EU. Therefore no influence of American patents on EU situation. However, there has been a summary judgment decision over the EU '417 patent, which is somewhat comparable to the '515 in the US. However claim construction differed materially from the current claim construction in the US.